Cargando…
Merging Ligand-Based and Structure-Based Methods in Drug Discovery: An Overview of Combined Virtual Screening Approaches
Virtual screening (VS) is an outstanding cornerstone in the drug discovery pipeline. A variety of computational approaches, which are generally classified as ligand-based (LB) and structure-based (SB) techniques, exploit key structural and physicochemical properties of ligands and targets to enable...
Autores principales: | Vázquez, Javier, López, Manel, Gibert, Enric, Herrero, Enric, Luque, F. Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587536/ https://www.ncbi.nlm.nih.gov/pubmed/33076254 http://dx.doi.org/10.3390/molecules25204723 |
Ejemplares similares
-
Combination of ligand and structure based virtual screening approaches for the discovery of potential PARP1 inhibitors
por: Al-Sanea, Mohammad M., et al.
Publicado: (2022) -
Discovery of High-Affinity
Amyloid Ligands Using a
Ligand-Based Virtual Screening Pipeline
por: Chisholm, Timothy S., et al.
Publicado: (2023) -
Discovery of Novel Androgen Receptor Ligands by Structure-based Virtual Screening and Bioassays
por: Zhou, Wenfang, et al.
Publicado: (2018) -
When drug discovery meets web search: Learning to Rank for ligand-based virtual screening
por: Zhang, Wei, et al.
Publicado: (2015) -
Discovery of a novel IKK-β inhibitor by ligand-based virtual screening techniques
por: Noha, Stefan M., et al.
Publicado: (2011)